Richard L. Huganir
| Richard L. Huganir | |
|---|---|
| Born | 25 March 1953 |
| Nationality | American |
| Fields | Neuroscience |
| Institutions | Johns Hopkins University |
Richard L. Huganir (born March 25, 1953) is a Professor and Director of the Solomon H. Snyder Department of Neuroscience, Director of the Kavli Neuroscience Discovery Institute and co-director of the Johns Hopkins Medicine Brain Science Institute at the Johns Hopkins University School of Medicine, as well as an Investigator with the Howard Hughes Medical Institute. He has joint appointments in the Department of Biological Chemistry and the Department of Pharmacology and Molecular Sciences. Huganir is also a member of the Cure Alzheimer's Fund's Research Consortium.
Dr. Huganir completed his undergraduate work in biochemistry at Vassar College in 1975. He received his Ph.D. degree in biochemistry, molecular and cell biology from Cornell University in 1982 where he performed his thesis research in the laboratory of Dr. Efraim Racker. He was a postdoctoral fellow with the Nobel Laureate, Dr. Paul Greengard, at Yale University School of Medicine from 1982 to 1984. Huganir then moved to the Rockefeller University where he was an Assistant Professor of Molecular and Cellular Neurobiology from 1984-1988.
Huganir moved to the Johns Hopkins University School of Medicine in 1988 as an Associate Investigator in the Howard Hughes Medical Institute and an Associate Professor in the Department of Neuroscience. Huganir became the Director or the Solomon H. Snyder Department of Neuroscience in 2006.
Dr. Huganir’s career has focused on synapses, the connections between nerve cells, in the brain. Dr. Huganir’s general approach has been to study molecular and cellular mechanisms that regulate neurotransmitter receptors. Dr. Huganir’s studies have shown that the regulation of receptor function is a major mechanism for the regulation of neuronal excitability and connectivity in the brain and is critical for many higher brain processes including learning and memory and the proper development of the brain. Moreover, dysregulation of these mechanisms underlie many neurological and psychiatric diseases in several neurological and psychiatric disorders including Alzheimer’s, ALS, schizophrenia, autism, intellectual disability, PTSD as well as in chronic pain and drug addiction.
...
Wikipedia